Many elderly patients put themselves at risk for emergency hospitalization due to adverse drug events, according to a new Centers for Disease Control and Prevention study published in the New England Journal of Medicine.

An investigational treatment made by Roche for asthma increased lung function in patients who could not adequately control their disease with inhaled corticosteroids, according to results of a mid-stage clinical trial.

An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

The National Advertising Division of the Council of Better Business Bureaus on Friday recommended that online distributor Supple Beverages discontinue a wide range of advertising claims for its Supple liquid glucosamine/chondroitin supplement, including weight-loss claims and speed-of-action claims.